BioSpace News Archive

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today reported preliminary revenue results for the full year and fourth quarter ended December 31, 2020.

Aligns legal charter with company’s long-term view and commitment to all stakeholders, including customers, employees, and shareholders Proposal passes by landslide as Veeva garners widespread support for leading in stakeholder capitalism

Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the pricing of its previously announced underwritten public offering of 6,250,000 shares of its common stock at a public offering price of $16.00 per share

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, presented at the J.P. Morgan 39th Annual Healthcare Conference (a virtual event) in the evening of January 13, Beijing Time

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that its anti-PD-1 antibody tislelizumab has received approval from the China National Medical Products Administration for use in combination with two chemotherapy regimens as a first-line treatment for patients with advanced squamous non-small cell lung cancer.

Talented Healthcare Executive with Excellent Medical Skills To Lead Growth of OrthoBethesda While Focusing on Quality Outcomes

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2020 results on Thursday, February 4, 2021 , before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eas

Description: The latest report on ‘global platelet aggregation devices market’ encompasses an exhaustive analysis of this business sphere, inclusive of historical data, qualitative insights, and verifiable projections for 2020-2027.

Description: The research report on ‘Global molecular biology enzymes, reagents and kits market’ meticulously studies this industry vertical, highlighting the predominant trends, growth driving factors, challenges, and opportunities that will shape the business dynamics during 2020-2027.

- Vuzix delivers remote servicing solutions to the medical device market to assist in compliance with COVID-19 travel and site visit restrictions